Skip to main content

Table 2 Gene Expression Data for Esophageal Cancer Patients in the ICU After POD 14

From: Prognostic impact of clinical course-specific mRNA expression profiles in the serum of perioperative patients with esophageal cancer in the ICU: a case control study

Pt.#

SCC

(ng/mL)

Cytokeratin fragment 19

(ng/mL)

CEA

(ng/mL)

hTERTmRNA

(logarithmic copy number)

Recurrence

Depth of tumor

invasion

#1

2.4

2.5

-

3.31

-

Mp

#2

-

-

-

3.9

-

Sm

#3

0.9

1.5

-

2.96

+

Ss

#4

< 0.5

1.4

-

4.41

-

Sm

#5

-

-

-

0

-

M

#6

2.0

1.6

-

0

+

Ss

#7

0.9

0.9

-

4.96

-

Sm

#8

< 0.5

1.9

-

0

-

Ss

#9

1.1

1.3

3.8

2.97

-

Ss

#10

1.2

2.1

1.0

3.58

-

Ss

#11

-

-

-

2.75

-

Ss

#12

0.8

0.9

-

2.14

-

Ss

#13

1.6

2.7

1.4

4.61

-

Sm

#14

2.7

-

3.1

3.99

-

Ss

#15

0.9

3.0

-

3.84

-

Ss

#16

-

-

-

3.81

-

Sm

#17

1.6

7.4

-

4.14

-

Mp

#18

1.3

0.9

2.4

4.53

-

Sm

#19

0.7

2.5

-

4.11

-

Sm

#20

3.9

3.1

2.4

4.41

-

Ss

#21

2.9

-

3.5

3.44

-

Mp

#22

0.7

2.2

-

4.35

-

Sm

#23

< 0.5

1.4

-

4.03

-

Ss

#24

1.4

-

-

3.89

-

M

#25

1.2

1.4

-

3.35

-

Ss

#26

-

-

-

4.39

-

M

#27

0.7

0.9

2.3

4.45

-

Mp

  1. -: not measured